Oncology Molecular Diagnostics Market
Oncology Molecular Diagnostics Market By Product (Oncology Molecular Diagnostic Reagents & Kits, Instruments, Services & Software), By Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH)), By End User, By Region - Global Insights to 2031
Analysis of Oncology Molecular Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Oncology Molecular Diagnostics Market Outlook
The global oncology molecular diagnostics market was valued at around US$ 1.7 Billion in 2020 and is anticipated to reach a valuation of US$ 4 Billion by 2031.
Demand for oncology molecular diagnostics is driven by increasing prevalence of infectious diseases and cancer, rising funding towards R&D, increase in PoC (point of care) testing devices, and various technological advancements.
Usage Analysis of Oncology Molecular Diagnostics from 2016 -2020 Vs Future Market Outlook for 2021 – 2031
According to Fact.MR, a market research and competitive intelligence provider, the global oncology molecular diagnostics market was estimated at US$ 1.3 Bn in 2016 and is anticipated to expand at a CAGR of 11% from 2021 to 2031. The market is being driven by sales of oncology molecular diagnostic instruments, kits, and reagents used for diagnosing cancer.
Molecular diagnostics are tests for oncology diagnose genetic information, proteins or related molecules, and provide health or disease information. This study is usually performed on blood, saliva, or tumor tissue samples.
Rise in the number of cancer cases across the globe is contributing to the growth of the market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019, in the U.S.
The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer. Therefore, rise in cancer incidence rate globally is anticipated to boost demand for oncology molecular diagnostic for cancer detection over the coming years.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
How Does Oncology Molecular Diagnostics Help in Early Detection?
Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins.
Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer.
These diagnostic solutions find application in clinical and point-of-care (PoC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.
What are the Main Factors Stimulating Demand for Oncology Based Molecular Diagnostics?
Rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and increasing trend of smoking represents one of the major factors driving global market growth.
Apart from this, escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques for oncology molecular diagnostics is contributing to the growth of the market.
Furthermore, rise in the number of individuals suffering from viral and bacterial infections and increasing participation in blood donation campaigns are positively influencing demand for oncology molecular diagnostic tests worldwide.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Key Restrains Affecting Sales of Oncology Molecular Diagnostics?
A molecular diagnostic instrument is expensive. The variable costs of the reagents needed, and those fixed by the suppliers thereof, add to the overall expenditure.
Furthermore, maintenance and insurance, laboratory supervision, and overhead costs (including utilities, space, and administration) are also additional expenses.
High volume of molecular diagnostic instruments may be affordable only for large hospitals and reference laboratories with good capital budgets. Most small laboratories, physician’s offices, and sole practitioners have no capital budgets and may not be able to afford a very large-sized analyzer.
Thus, high-cost requirements might restrain the growth of the cancer molecular diagnostics market over the coming years.
What are the Key Trends in the Oncology Molecular Diagnostics Market?
Advanced technology in genomics is a key trend in the said market. Advancements in cancer genome sequencing technology, computational analysis, tumor models, and innovation of modern cancer research methods promote early detection of cancer and its mutation.
For instance, Roche Molecular Systems, a U.S.-based company, developed Cobas EGFR Mutation Test for non-small cell lung cancer patients. This test is a real-time test that detects 42 mutations of the epidermal growth factor receptor (EGFR) gene, along with the resistant mutation of cancer. In June 2020, FDA approved Cobas EGFR Mutation Test.
Such technological advancements are playing a major role in promoting the usage of molecular diagnostic tests for oncology.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Regional Opportunities Awaiting Manufacturers of Oncology Molecular Diagnostics?
North America accounts for the largest share of around 34% of the global market. The North America’s market growth can be attributed to the highly developed healthcare system in the U.S. and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.
The market in Asia Pacific is expected to expand at the fastest CAGR of 16% during the forecast period. Increasing incidence of cancer among the low- and middle-income population in the Asia Pacific region can be attributed to the aging populations and changes in lifestyle associated with economic development and epidemiologic transition.
India, China, and Australia are expected to offer immense potential for this industry, mainly due to growing economy and high unmet medical needs.
Demand for oncology molecular diagnostic instruments in China is set to expand at a CAGR of 9% across the assessment period. Also, sales of molecular diagnostic kits in Australia are expected to increase significantly over the next ten years.
Country-wise Analysis
Will the U.S. Remain a Lucrative Market for Suppliers of Oncology Molecular Diagnostics?
The U.S. oncology molecular diagnostics market was estimated at US$ 491 Mn in 2020. Incidence of cancer cases have been on the rise since many years in the country.
Most common sites of cancer are lung, liver, stomach, colorectal, and breast. Hence the rising cancer cases are driving the sales of oncology molecular diagnostics in the country.
Furthermore, rising awareness levels among patients and healthcare professionals for early detection and differentiation of cancer is estimated to enhance the usage rates of molecular diagnostic techniques for oncology.
Category-wise Analysis
Will Demand for Reagents & Kits Remain High Across the Assessment Period?
The reagents & kits segment accounts for the largest share in this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.
Demand for oncology molecular diagnostic reagents & kits is estimated to expand at a CAGR of 12.8% across the assessment period.
Why is Demand for PCR in Oncology Molecular Diagnostics Dominating the Market?
The polymerase chain reaction (PCR) segment accounted for the largest market share by technology. This can be attributed to the growing use of PCR in proteomics and genomics, use of RT-PCR in COVID-19 test, automation of PCR instruments, and the emergence of advanced technologies like qRT-PCR (Real-Time Quantitative Reverse Transcription PCR) drive this segment's growth.
Competitive Landscape
Top service providers of oncology molecular diagnostics, in an attempt to gain stability, are adopting strategies such as specialized product development. Leading market players in oncology molecular diagnostics are also entering into collaborations with top oncology molecular diagnostic instrument brands, for development of companion diagnostic pertaining to cancer.
Some of the key developments are:
- In September 2015; Roche launched the Cobas EGFR Mutation Test v2, which is used for diagnosis of Non-Small Cell Lung Cancer (NSCLC), which is expected to drive the growth of this market.
- Qiagen and Lilly announced their plans to co-develop companion diagnostics for targeting common cancer biomarkers.
- In February 2019, ICON plc, a US-based biotechnology company, acquired MolecularMD for an undisclosed amount. The acquisition enhances ICON’s laboratory offering in molecular diagnostic testing and brings to ICON expanded testing platforms, including next-generation sequencing, and immunohistochemistry (IHC).
Oncology Molecular Diagnostic Market Report Scope
|
Attribute |
Details |
|
Market size value in 2020 |
USD 1.7 Billion |
|
Market forecast value in 2031 |
USD 4 Billion |
|
Growth Rate |
CAGR of 11% from 2021 to 2031 |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
US$ Mn for Value & ‘000 Units for Volume |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments Covered in Oncology Molecular Diagnostic Industry Research
-
By Product
- Oncology Molecular Diagnostic Reagents & Kits
- Oncology Molecular Diagnostic Instruments
- Oncology Molecular Diagnostic Tabletop Instruments
- Oncology Molecular Diagnostic Portable & PoC Instruments
- Oncology Molecular Diagnostic Services & Software
-
By Technology
- Polymerase Chain Reaction (PCR) in Oncology Molecular Diagnostics
- Isothermal Nucleic Acid Amplification Technology (INAAT) for Oncology Molecular Diagnostics
- DNA Sequencing & Next-Generation Sequencing (NGS) for Oncology Molecular Diagnostics
- In Situ Hybridization (ISH) Technology for Oncology Molecular Diagnostics
- DNA Chips and Microarrays for Oncology Molecular Diagnostics
-
By End User
- Oncology Molecular Diagnostic Used in Diagnostic Laboratories
- Oncology Molecular Diagnostic Used in Hospitals & Clinics
Table of Content
1. Global Oncology Molecular Diagnostic Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and recommendation 2. Global Oncology Molecular Diagnostic Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Oncology Molecular Diagnostic 3.1.2. COVID-19 Crisis and Impact on Oncology Molecular Diagnostic Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Oncology Molecular Diagnostic Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2020 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendation for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Technology Development Trends 4. Market Background and foundation Data Points 4.1. Manufacturing Sector Reached here in Leaps and Bounds 4.2. Need of the Hour for Industries 4.3. Manufacturing Sector at Fore-Front of Technology Adoption 4.4. Industry Wise Industry 4.0 4.5. Oncology Molecular Diagnostic – Strategic Priorities 4.6. Technology life Cycle Stage 4.7. Importance of Technology 4.8. Oncology Molecular Diagnostic: Hype Cycle 4.9. 5 Reasons to Implement Oncology Molecular Diagnostic 4.10. Oncology Molecular Diagnostic Technology 4.11. A Concluding Gap in Industrial Digitization 4.12. 5G – Future of Communications Platform 4.13. 5G vs 4G Comparison 4.14. Use Cases of Oncology Molecular Diagnostic in Manufacturing 4.15. Forecast Factors: Relevance and Impact 4.16. Investment Feasibility Matrix 4.17. PESTLE Analysis 4.18. Porter’s Five Forces Analysis 4.19. Market Dynamics 4.19.1. Drivers 4.19.2. Restraints 4.19.3. Opportunity Analysis 4.19.4. Trend 5. Global Oncology Molecular Diagnostic Market Demand (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031 5.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 5.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031, By Technology 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Technology, 2016-2020 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Technology, 2021-2031 6.3.1. Polymerase Chain Reaction (PCR) 6.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 6.3.3. DNA Sequencing & Next-Generation Sequencing (NGS) 6.3.4. In Situ Hybridization (ISH) 6.3.5. DNA Microarrays 6.4. Market Attractiveness Analysis By Technology 7. Global Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031, by Product 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Product , 2016-2020 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2021-2031 7.3.1. Reagents & Kits 7.3.2. Instruments 7.3.3. Services & Software 7.4. Market Attractiveness Analysis By Product 8. Global Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2016-2020 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2021-2031 8.3.1. Diagnostic Laboratories 8.3.2. Hospitals & Clinics 8.4. Market Attractiveness Analysis By End User 9. Global Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2016-2020 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Technology 10.3.3. By Product 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Technology 10.4.3. By Product 11. Latin America Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Technology 11.3.3. By Product 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Technology 11.4.3. By Product 11.4.4. By End User 12. Europe Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. UK 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Technology 12.3.3. By Product 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Technology 12.4.3. By Product 12.4.4. By End User 13. East Asia Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Technology 13.3.3. By Product 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Technology 13.4.3. By Product 13.4.4. By End User 14. South Asia & Oceania Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Technology 14.3.3. By Product 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Technology 14.4.3. By Product 14.4.4. By End User 15. Middle East and Africa Oncology Molecular Diagnostic Market Analysis 2016-2020 and Forecast 2021-2031 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Technology 15.3.3. By Product 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Technology 15.4.3. By Product 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.4. F. Hoffmann-La Roche Ltd 17.4.1. Company Overview 17.4.2. Technology overview 17.4.3. SWOT Analysis 17.4.4. Key Developments 17.5. Hologic 17.5.1. Company Overview 17.5.2. Technology overview 17.5.3. SWOT Analysis 17.5.4. Key Developments 17.6. BioMérieux SA 17.6.1. Company Overview 17.6.2. Technology overview 17.6.3. SWOT Analysis 17.6.4. Key Developments 17.7. Abbott Laboratories 17.7.1. Company Overview 17.7.2. Technology overview 17.7.3. SWOT Analysis 17.7.4. Key Developments 17.8. QIAGEN 17.8.1. Company Overview 17.8.2. Technology overview 17.8.3. SWOT Analysis 17.8.4. Key Developments 17.9. Thermo Fisher Scientific Inc. 17.9.1. Company Overview 17.9.2. Technology overview 17.9.3. SWOT Analysis 17.9.4. Key Developments 17.10. Siemens Healthineers AG 17.10.1. Company Overview 17.10.2. Technology overview 17.10.3. SWOT Analysis 17.10.4. Key Developments 17.11. Danaher Corporation 17.11.1. Company Overview 17.11.2. Technology overview 17.11.3. SWOT Analysis 17.11.4. Key Developments 17.12. Myriad Genetics Inc. 17.12.1. Company Overview 17.12.2. Technology overview 17.12.3. SWOT Analysis 17.12.4. Key Developments 17.13. Illumina Inc. 17.13.1. Company Overview 17.13.2. Technology overview 17.13.3. SWOT Analysis 17.13.4. Key Developments 17.14. Agilent Technologies Inc. 17.14.1. Company Overview 17.14.2. Technology overview 17.14.3. SWOT Analysis 17.14.4. Key Developments 17.15. Becton, Dickinson and Company 17.15.1. Company Overview 17.15.2. Technology overview 17.15.3. SWOT Analysis 17.15.4. Key Developments 17.16. DiaSorin S.p.A, Grifols 17.16.1. Company Overview 17.16.2. Technology overview 17.16.3. SWOT Analysis 17.16.4. Key Developments 17.17. Quidel Corporation 17.17.1. Company Overview 17.17.2. Technology overview 17.17.3. SWOT Analysis 17.17.4. Key Developments 17.18. Genetic Signatures 17.18.1. Company Overview 17.18.2. Technology overview 17.18.3. SWOT Analysis 17.18.4. Key Developments 17.19. MDxHealth 17.19.1. Company Overview 17.19.2. Technology overview 17.19.3. SWOT Analysis 17.19.4. Key Developments 17.20. Exact Sciences Corporation 17.20.1. Company Overview 17.20.2. Technology overview 17.20.3. SWOT Analysis 17.20.4. Key Developments 17.21. Biocartis NV 17.21.1. Company Overview 17.21.2. Technology overview 17.21.3. SWOT Analysis 17.21.4. Key Developments 17.22. TBG Diagnostics Ltd. 17.22.1. Company Overview 17.22.2. Technology overview 17.22.3. SWOT Analysis 17.22.4. Key Developments 17.23. GenMark Diagnostics Inc. 17.23.1. Company Overview 17.23.2. Technology overview 17.23.3. SWOT Analysis 17.23.4. Key Developments 17.24. Luminex Corporation 17.24.1. Company Overview 17.24.2. Technology overview 17.24.3. SWOT Analysis 17.24.4. Key Developments 17.25. HTG Molecular Diagnostics Inc. 17.25.1. Company Overview 17.25.2. Technology overview 17.25.3. SWOT Analysis 17.25.4. Key Developments 17.26. Vela Diagnostics 17.26.1. Company Overview 17.26.2. Technology overview 17.26.3. SWOT Analysis 17.26.4. Key Developments 17.27. Amoy Diagnostics Co. 17.27.1. Company Overview 17.27.2. Technology overview 17.27.3. SWOT Analysis 17.27.4. Key Developments 17.28. Molbio Diagnostics Pvt. Ltd. 17.28.1. Company Overview 17.28.2. Technology overview 17.28.3. SWOT Analysis 17.28.4. Key Developments 17.29. ELITechGroup 17.29.1. Company Overview 17.29.2. Technology overview 17.29.3. SWOT Analysis 17.29.4. Key Developments 17.30. Savyon Diagnostics Ltd 17.30.1. Company Overview 17.30.2. Technology overview 17.30.3. SWOT Analysis 17.30.4. Key Developments 17.31. ABACUS Diagnostica Oy 17.31.1. Company Overview 17.31.2. Technology overview 17.31.3. SWOT Analysis 17.31.4. Key Developments 17.32. GeneOmbio Technologies Pvt. Ltd. 17.32.1. Company Overview 17.32.2. Technology overview 17.32.3. SWOT Analysis 17.32.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2016-2020
Table 2: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2021-2031
Table 3: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Technology, 2021-2031
Table 4: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 5: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 6: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 7: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 8: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 9: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 10: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Region, 2016-2020
Table 11: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Region, 2021-2031
Table 12: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Region, 2021-2031
Table 13: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 14: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 15: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 16: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2016-2020
Table 17: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2021-2031
Table 18: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Technology, 2021-2031
Table 19: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 20: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 21: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 22: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 23: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 24: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 25: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 26: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 27: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 28: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2016-2020
Table 29: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2021-2031
Table 30: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Technology, 2021-2031
Table 31: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 32: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 33: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 34: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 35: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 36: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 37: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 38: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 39: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 40: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2016-2020
Table 41: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2021-2031
Table 42: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Technology, 2021-2031
Table 43: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 44: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 45: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 46: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 47: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 48: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 49: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 50: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 51: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 52: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2016-2020
Table 53: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2021-2031
Table 54: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Technology, 2021-2031
Table 55: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 56: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 57: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 58: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 59: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 60: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 61: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 62: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 63: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 64: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2016-2020
Table 65: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2021-2031
Table 66: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Technology, 2021-2031
Table 67: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 68: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 69: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 70: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 71: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 72: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 73: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 74: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 75: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 76: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2016-2020
Table 77: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Technology, 2021-2031
Table 78: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Technology, 2021-2031
Table 79: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 80: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 81: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 82: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 83: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 84: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 2: Global Oncology Molecular Diagnostic Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 3: Global Oncology Molecular Diagnostic Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 4: Global Oncology Molecular Diagnostic Market Incremental $ Opportunity, 2021-2031
Figure 5: Global Oncology Molecular Diagnostic Market Share and BPS Analysis by Technology, 2021 & 2031
Figure 6: Global Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Technology, 2021-2031
Figure 7: Global Oncology Molecular Diagnostic Market Attractiveness Analysis by Technology, 2021-2031
Figure 8: Global Oncology Molecular Diagnostic Market Share and BPS Analysis by Product, 2021 & 2031
Figure 9: Global Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 10: Global Oncology Molecular Diagnostic Market Attractiveness Analysis by Product, 2021-2031
Figure 11: Global Oncology Molecular Diagnostic Market Share and BPS Analysis by End User, 2021 & 2031
Figure 12: Global Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 13: Global Oncology Molecular Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 14: Global Oncology Molecular Diagnostic Market Share and BPS Analysis by Region, 2021 & 2031
Figure 15: Global Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Region, 2021-2031
Figure 16: Global Oncology Molecular Diagnostic Market Attractiveness Analysis by Region, 2021-2031
Figure 17: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 18: North America Oncology Molecular Diagnostic Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 19: North America Oncology Molecular Diagnostic Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 20: North America Oncology Molecular Diagnostic Market Incremental $ Opportunity, 2021-2031
Figure 21: North America Oncology Molecular Diagnostic Market Share Analysis by Country, 2021 & 2031
Figure 22: North America Oncology Molecular Diagnostic Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 23: North America Oncology Molecular Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 24: North America Oncology Molecular Diagnostic Market Share and BPS Analysis by Technology, 2021 & 2031
Figure 25: North America Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Technology, 2021-2031
Figure 26: North America Oncology Molecular Diagnostic Market Attractiveness Analysis by Technology, 2021-2031
Figure 27: North America Oncology Molecular Diagnostic Market Share and BPS Analysis by Product, 2021 & 2031
Figure 28: North America Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 29: North America Oncology Molecular Diagnostic Market Attractiveness Analysis by Product, 2021-2031
Figure 30: North America Oncology Molecular Diagnostic Market Share and BPS Analysis by End User, 2021 & 2031
Figure 31: North America Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 32: North America Oncology Molecular Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 33: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 34: Latin America Oncology Molecular Diagnostic Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 35: Latin America Oncology Molecular Diagnostic Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 36: Latin America Oncology Molecular Diagnostic Market Incremental $ Opportunity, 2021-2031
Figure 37: Latin America Oncology Molecular Diagnostic Market Share Analysis by Country, 2021 & 2031
Figure 38: Latin America Oncology Molecular Diagnostic Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 39: Latin America Oncology Molecular Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 40: Latin America Oncology Molecular Diagnostic Market Share and BPS Analysis by Technology, 2021 & 2031
Figure 41: Latin America Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Technology, 2021-2031
Figure 42: Latin America Oncology Molecular Diagnostic Market Attractiveness Analysis by Technology, 2021-2031
Figure 43: Latin America Oncology Molecular Diagnostic Market Share and BPS Analysis by Product, 2021 & 2031
Figure 44: Latin America Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 45: Latin America Oncology Molecular Diagnostic Market Attractiveness Analysis by Product, 2021-2031
Figure 46: Latin America Oncology Molecular Diagnostic Market Share and BPS Analysis by End User, 2021 & 2031
Figure 47: Latin America Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 48: Latin America Oncology Molecular Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 49: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 50: Europe Oncology Molecular Diagnostic Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 51: Europe Oncology Molecular Diagnostic Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 52: Europe Oncology Molecular Diagnostic Market Incremental $ Opportunity, 2021-2031
Figure 53: Europe Oncology Molecular Diagnostic Market Share Analysis by Country, 2021 & 2031
Figure 54: Europe Oncology Molecular Diagnostic Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 55: Europe Oncology Molecular Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 56: Europe Oncology Molecular Diagnostic Market Share and BPS Analysis by Technology, 2021 & 2031
Figure 57: Europe Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Technology, 2021-2031
Figure 58: Europe Oncology Molecular Diagnostic Market Attractiveness Analysis by Technology, 2021-2031
Figure 59: Europe Oncology Molecular Diagnostic Market Share and BPS Analysis by Product, 2021 & 2031
Figure 60: Europe Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 61: Europe Oncology Molecular Diagnostic Market Attractiveness Analysis by Product, 2021-2031
Figure 62: Europe Oncology Molecular Diagnostic Market Share and BPS Analysis by End User, 2021 & 2031
Figure 63: Europe Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 64: Europe Oncology Molecular Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 65: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 66: East Asia Oncology Molecular Diagnostic Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 67: East Asia Oncology Molecular Diagnostic Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 68: East Asia Oncology Molecular Diagnostic Market Incremental $ Opportunity, 2021-2031
Figure 69: East Asia Oncology Molecular Diagnostic Market Share Analysis by Country, 2021 & 2031
Figure 70: East Asia Oncology Molecular Diagnostic Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 71: East Asia Oncology Molecular Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 72: East Asia Oncology Molecular Diagnostic Market Share and BPS Analysis by Technology, 2021 & 2031
Figure 73: East Asia Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Technology, 2021-2031
Figure 74: East Asia Oncology Molecular Diagnostic Market Attractiveness Analysis by Technology, 2021-2031
Figure 75: East Asia Oncology Molecular Diagnostic Market Share and BPS Analysis by Product, 2021 & 2031
Figure 76: East Asia Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 77: East Asia Oncology Molecular Diagnostic Market Attractiveness Analysis by Product, 2021-2031
Figure 78: East Asia Oncology Molecular Diagnostic Market Share and BPS Analysis by End User, 2021 & 2031
Figure 79: East Asia Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 80: East Asia Oncology Molecular Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 81: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 82: South Asia & Oceania Oncology Molecular Diagnostic Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 83: South Asia & Oceania Oncology Molecular Diagnostic Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 84: South Asia & Oceania Oncology Molecular Diagnostic Market Incremental $ Opportunity, 2021-2031
Figure 85: South Asia & Oceania Oncology Molecular Diagnostic Market Share Analysis by Country, 2021 & 2031
Figure 86: South Asia & Oceania Oncology Molecular Diagnostic Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 87: South Asia & Oceania Oncology Molecular Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 88: South Asia & Oceania Oncology Molecular Diagnostic Market Share and BPS Analysis by Technology, 2021 & 2031
Figure 89: South Asia & Oceania Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Technology, 2021-2031
Figure 90: South Asia & Oceania Oncology Molecular Diagnostic Market Attractiveness Analysis by Technology, 2021-2031
Figure 91: South Asia & Oceania Oncology Molecular Diagnostic Market Share and BPS Analysis by Product, 2021 & 2031
Figure 92: South Asia & Oceania Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 93: South Asia & Oceania Oncology Molecular Diagnostic Market Attractiveness Analysis by Product, 2021-2031
Figure 94: South Asia & Oceania Oncology Molecular Diagnostic Market Share and BPS Analysis by End User, 2021 & 2031
Figure 95: South Asia & Oceania Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 96: South Asia & Oceania Oncology Molecular Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Figure 97: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 98: MEA Oncology Molecular Diagnostic Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 99: MEA Oncology Molecular Diagnostic Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 100: MEA Oncology Molecular Diagnostic Market Incremental $ Opportunity, 2021-2031
Figure 101: MEA Oncology Molecular Diagnostic Market Share Analysis by Country, 2021 & 2031
Figure 102: MEA Oncology Molecular Diagnostic Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 103: MEA Oncology Molecular Diagnostic Market Attractiveness Analysis by Country, 2021-2031
Figure 104: MEA Oncology Molecular Diagnostic Market Share and BPS Analysis by Technology, 2021 & 2031
Figure 105: MEA Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Technology, 2021-2031
Figure 106: MEA Oncology Molecular Diagnostic Market Attractiveness Analysis by Technology, 2021-2031
Figure 107: MEA Oncology Molecular Diagnostic Market Share and BPS Analysis by Product, 2021 & 2031
Figure 108: MEA Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 109: MEA Oncology Molecular Diagnostic Market Attractiveness Analysis by Product, 2021-2031
Figure 110: MEA Oncology Molecular Diagnostic Market Share and BPS Analysis by End User, 2021 & 2031
Figure 111: MEA Oncology Molecular Diagnostic Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 112: MEA Oncology Molecular Diagnostic Market Attractiveness Analysis by End User, 2021-2031
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What are the challenges impacting the market for oncology molecular diagnostics?
Challenges affecting the market are changing regulatory landscape, operational barriers, and introduction of alternative technologies.
What are the different types of oncology molecular diagnostic instruments used?
Different types of instruments are tabletop and portable & point-of-care instruments.
Who are the key end users of oncology molecular diagnostics?
Based on key end users, the market is segmented into diagnostic laboratories, hospitals, and clinics.
What is the expected growth rate of the market?
The global oncology molecular diagnostic market is expected to expand at a CAGR of 11% across the forecast period.
Which region is set to be a lucrative market for oncology molecular diagnostics?
Emerging economies in the Asia Pacific region will be lucrative markets for oncology molecular diagnostics over the next ten years.
Which diagnostic technology dominates the market?
Polymerase chain reaction (PCR) diagnostic technology dominates the market due to its robust results and early detection.
Which are the different types of cancers for detection of which mass spectrometry is used?
Mass spectrometry is used for oncology molecular diagnostics of colorectal cancer, blood cancer, and lung cancer.
Loop-mediated isothermal amplification (LAMP) is used for the diagnosis of which tumours?
Loop-mediated isothermal amplification is used for oncology molecular diagnosis of prostate cancer, liver cancer, and cervical cancer.
Who are the top manufacturers of oncology molecular diagnostic kits?
Roche, QIAGEN, Hologic, Grifols, and Abbott Laboratories are some of the top manufacturers of oncology molecular diagnostic kits.
What are the latest trends related to oncology molecular diagnostic tests?
Rising demand for PCR in oncology molecular diagnostics is the latest trend in the market.
Why is demand for PCR in oncology molecular diagnostics in Germany on the rise?
Due to rising cases of oncology in Germany, use of PCR for oncology molecular diagnostics is growing in the country.
How is demand for oncology molecular diagnostic instruments shaping up in China?
Demand for oncology molecular diagnostic instruments in China is expected to expand at a CAGR of 7% through 2031.
Oncology Molecular Diagnostics Market